Literature DB >> 24106950

Genomic landscapes and clonality of de novo AML.

Christopher A Miller, Richard K Wilson, Timothy J Ley.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24106950      PMCID： PMC4374653          DOI： 10.1056/NEJMc1308782

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

1.  The origin and evolution of mutations in acute myeloid leukemia.

Authors:  John S Welch; Timothy J Ley; Daniel C Link; Christopher A Miller; David E Larson; Daniel C Koboldt; Lukas D Wartman; Tamara L Lamprecht; Fulu Liu; Jun Xia; Cyriac Kandoth; Robert S Fulton; Michael D McLellan; David J Dooling; John W Wallis; Ken Chen; Christopher C Harris; Heather K Schmidt; Joelle M Kalicki-Veizer; Charles Lu; Qunyuan Zhang; Ling Lin; Michelle D O'Laughlin; Joshua F McMichael; Kim D Delehaunty; Lucinda A Fulton; Vincent J Magrini; Sean D McGrath; Ryan T Demeter; Tammi L Vickery; Jasreet Hundal; Lisa L Cook; Gary W Swift; Jerry P Reed; Patricia A Alldredge; Todd N Wylie; Jason R Walker; Mark A Watson; Sharon E Heath; William D Shannon; Nobish Varghese; Rakesh Nagarajan; Jacqueline E Payton; Jack D Baty; Shashikant Kulkarni; Jeffery M Klco; Michael H Tomasson; Peter Westervelt; Matthew J Walter; Timothy A Graubert; John F DiPersio; Li Ding; Elaine R Mardis; Richard K Wilson
Journal:  Cell       Date:  2012-07-20       Impact factor: 41.582

2.  Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing.

Authors:  Li Ding; Timothy J Ley; David E Larson; Christopher A Miller; Daniel C Koboldt; John S Welch; Julie K Ritchey; Margaret A Young; Tamara Lamprecht; Michael D McLellan; Joshua F McMichael; John W Wallis; Charles Lu; Dong Shen; Christopher C Harris; David J Dooling; Robert S Fulton; Lucinda L Fulton; Ken Chen; Heather Schmidt; Joelle Kalicki-Veizer; Vincent J Magrini; Lisa Cook; Sean D McGrath; Tammi L Vickery; Michael C Wendl; Sharon Heath; Mark A Watson; Daniel C Link; Michael H Tomasson; William D Shannon; Jacqueline E Payton; Shashikant Kulkarni; Peter Westervelt; Matthew J Walter; Timothy A Graubert; Elaine R Mardis; Richard K Wilson; John F DiPersio
Journal:  Nature       Date:  2012-01-11       Impact factor: 49.962
  2 in total
  25 in total

1.  The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramers.

Authors:  David A Russler-Germain; David H Spencer; Margaret A Young; Tamara L Lamprecht; Christopher A Miller; Robert Fulton; Matthew R Meyer; Petra Erdmann-Gilmore; R Reid Townsend; Richard K Wilson; Timothy J Ley
Journal:  Cancer Cell       Date:  2014-03-20       Impact factor: 31.743

2.  Cellular origin of prognostic chromosomal aberrations in AML patients.

Authors:  H Mora-Jensen; J Jendholm; N Rapin; M K Andersen; A S Roug; F O Bagger; L Bullinger; O Winther; N Borregaard; B T Porse; K Theilgaard-Mönch
Journal:  Leukemia       Date:  2015-02-11       Impact factor: 11.528

3.  Impact of FLT3-ITD diversity on response to induction chemotherapy in patients with acute myeloid leukemia.

Authors:  Mike Fischer; Ulf Schnetzke; Bärbel Spies-Weisshart; Mario Walther; Maximilian Fleischmann; Inken Hilgendorf; Andreas Hochhaus; Sebastian Scholl
Journal:  Haematologica       Date:  2016-12-29       Impact factor: 9.941

4.  FLT3-ITD impedes retinoic acid, but not arsenic, responses in murine acute promyelocytic leukemias.

Authors:  Cécile Esnault; Ramy Rahmé; Kim L Rice; Caroline Berthier; Coline Gaillard; Samuel Quentin; Anne-Lise Maubert; Scott Kogan; Hugues de Thé
Journal:  Blood       Date:  2019-01-23       Impact factor: 22.113

Review 5.  Mutant DNA methylation regulators endow hematopoietic stem cells with the preleukemic stem cell property, a requisite of leukemia initiation and relapse.

Authors:  Yuting Tan; Han Liu; Saijuan Chen
Journal:  Front Med       Date:  2015-12       Impact factor: 4.592

6.  WT1 mutations are secondary events in AML, show varying frequencies and impact on prognosis between genetic subgroups.

Authors:  M-T Krauth; T Alpermann; U Bacher; C Eder; F Dicker; M Ulke; S Kuznia; N Nadarajah; W Kern; C Haferlach; T Haferlach; S Schnittger
Journal:  Leukemia       Date:  2014-08-11       Impact factor: 11.528

7.  NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report.

Authors:  Fabiana Ostronoff; Megan Othus; Robert B Gerbing; Michael R Loken; Susana C Raimondi; Betsy A Hirsch; Beverly J Lange; Stephen Petersdorf; Jerald Radich; Frederick R Appelbaum; Alan S Gamis; Todd A Alonzo; Soheil Meshinchi
Journal:  Blood       Date:  2014-08-21       Impact factor: 22.113

8.  Juvenile myelomonocytic leukemia-associated variants are associated with neo-natal lethal Noonan syndrome.

Authors:  Heather Mason-Suares; Diana Toledo; Jean Gekas; Katherine A Lafferty; Naomi Meeks; M Cristina Pacheco; David Sharpe; Thomas E Mullen; Matthew S Lebo
Journal:  Eur J Hum Genet       Date:  2017-01-18       Impact factor: 4.246

9.  MEIS1 regulates an HLF-oxidative stress axis in MLL-fusion gene leukemia.

Authors:  Jayeeta Roychoudhury; Jason P Clark; Gabriel Gracia-Maldonado; Zeenath Unnisa; Mark Wunderlich; Kevin A Link; Nupur Dasgupta; Bruce Aronow; Gang Huang; James C Mulloy; Ashish R Kumar
Journal:  Blood       Date:  2015-03-04       Impact factor: 22.113

10.  Dnmt3b Methylates DNA by a Noncooperative Mechanism, and Its Activity Is Unaffected by Manipulations at the Predicted Dimer Interface.

Authors:  Allison B Norvil; Christopher J Petell; Lama Alabdi; Lanchen Wu; Sandra Rossie; Humaira Gowher
Journal:  Biochemistry       Date:  2016-11-04       Impact factor: 3.162
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.